1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow F16IL2: new trials by email Literature Review of F16IL2 trials Research Report on F16IL2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation F16IL2, cytarabine - Acute Myeloid Leukemia, Relapsed, Adult | Phase 1 | Terminated | Philogen S.p.A. | 30 | 2016-04-13 | 2023-10-10 |
Leukemia, Myeloid, Acute (1) · Recurrence (1)
Philogen S.p.A. (1)
Germany (1)